journal article Open Access Nov 24, 2022

Comparison of hypoxia-induced pulmonary hypertension rat models caused by different hypoxia protocols

View at Publisher Save 10.1080/01902148.2022.2148016
Topics

No keywords indexed for this article. Browse by subject →

References
26
[1]
An overview of the 6th World Symposium on Pulmonary Hypertension

Nazzareno Galiè, Vallerie V. McLaughlin, Lewis J. Rubin et al.

European Respiratory Journal 10.1183/13993003.02148-2018
[2]
Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Gérald Simonneau, David Montani, David S. Celermajer et al.

European Respiratory Journal 10.1183/13993003.01913-2018
[13]
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

Kurt R. Stenmark, Barbara Meyrick, Nazzareno Galiè et al.

American Journal of Physiology-Lung Cellular and M... 10.1152/ajplung.00217.2009
[20]
Chen M, Cai H, Yu C, et al. Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways. Am J Transl Res. 2016;8(1):12–27.
[21]
Ma TT, Wang Y, Zhou XL, et al. Research on rat models of hypobaric hypoxia-induced pulmonary hypertension. Eur Rev Med Pharmacol Sci. 2015;19(19):3723–3730.
[25]
Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol. 1976;57(5):542–554.